Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

An experimental drug may slow the progression of a form of multiple sclerosis that increases disability relentlessly, a new ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...